Since 2013, McGill has honoured 30 early-career researchers who have distinguished themselves by their exceptional contributions to research through the President’s Prize for Outstanding Emerging Researchers. Among this year’s recipients is Jianyu Li, Associate Professor in the Department of Mechanical Engineering in the Faculty of Engineering and Canada Research Chair in Biomaterials and Muscoskeletal Health (Tier II). Professors (Faculty of Law) and (Faculty of Education) are also honoured with the prize.
“These three exceptional emerging scholars exhibit a remarkable record of research and teaching accomplishments, proving themselves as leaders in their field now and into the future,” said Deep Saini, Principal and Vice-Chancellor. “Their dedication and talent in addressing vital issues inspires us all.”
Administered by the Office of the Vice-President, Research and Innovation, the prize, which includes a monetary award, honours individuals across all disciplines.
Engineering innovative technologies to address critical challenges in clinical settings
Every year, around two million people die from hemorrhage or blood loss. But what if new technologies can help remedy this?
Working at the intersection of mechanics, chemistry and biomedical engineering, Li is leading highly innovative research focusing on finding a solution to this global health issue. With the help of his lab, Li’s research is focused on enabling technologies to improve health and address critical clinical problems, including hemorrhage control, wound healing, and the repair and regeneration of intervertebral discs and meniscuses.
“Receiving the President’s Prize is a true honour, and I’m deeply thankful for the support from my research team and department that made this possible,” says Li.
A pioneer in the world of biomaterials
As an early career researcher, Li has established an innovative and transdisciplinary research program at McGill. In addition to attracting millions of dollars in funding from numerous granting agencies, Li’s expertise in biomaterials and bioadhesive technologies is acknowledged around the world with 55 published articles to date in high-profile journals and over 100 speaking engagements in Canada and internationally.
Changing the future of clinical practices
In addition to his numerous research contributions, Li is also an active participant in technology transfer and commercialization. He has created seven patents and successfully launched ClickClot, a spin-off company dedicated to commercializing a novel hemostatic technology developed in his lab that can quickly stop heavy bleeding
“The invaluable support from McGill Engine and the Technology Transfer Office has been instrumental in facilitating technology transfer and fostering entrepreneurship, allowing research innovations to make impacts beyond the laboratory,” says Li. “McGill’s vibrant research environment and collaborative partnerships have been pivotal in advancing my transdisciplinary research and enriching its impact.”
This article was originally published in the .